At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jun 17, 2026 at 16:08 ET
Three top executives (CEO, CMO, CCO) at Dyne Therapeutics sold a combined ~$68K in shares on June 16, 2026, the same day the company announced a $50M draw on its expanded $400M Hercules Capital debt facility. The dollar amount is negligible, ~0.002% of the company's $3.0B market cap, making this a routine, non-informative insider sale cluster with no actionable signal.
- CEO John Cox sold 2,683 shares for ~$49K at $18.33/share on June 16.
- CMO Douglas Kerr sold 887 shares for ~$16K at $18.33/share.
- CCO Johanna Friedl-Naderer sold 145 shares for ~$3K at $18.33/share.
- Total insider sales of $68K represent ~0.0023% of DYN's $3.0B market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access